Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYNB1020 in Healthy Volunteers
NCT03179878Phase 1Completed
- Sponsor
- Synlogic
- Start
- Jun 2017
- Primary completion
- Nov 2017
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in urea cycle disorders (UCD) comparing SYNB1020 with Placebo (2 arms). Primary endpoint: Incidence of Treatment-Emergent Adverse Events, Laboratory Assessments and ECGs at 3 months. Started Jun 2017; status: completed.
02
Drugs
SYNB1020
03
Conditions
urea cycle disorders (UCD)
Beyond the preview
Go deeper on NCT03179878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03179878.